FOXA
59
4
NAVI
47
3
EMN
56
7
XYL
45
8
C
60
2
DHI
44
-4
HST
58
18
ALLE
44
7
LRCX
45
6
JNJ
44
3
DRI
48
3
HAL
60
2
QRVO
8
4
KLAC
43
4
FITB
60
2
EXPE
91
3
EXPD
45
8
ROK
47
-8
RHI
57
3
MDLZ
36
2
FOXA
59
4
NAVI
47
3
EMN
56
7
XYL
45
8
C
60
2
DHI
44
-4
HST
58
18
ALLE
44
7
LRCX
45
6
JNJ
44
3
DRI
48
3
HAL
60
2
QRVO
8
4
KLAC
43
4
FITB
60
2
EXPE
91
3
EXPD
45
8
ROK
47
-8
RHI
57
3
MDLZ
36
2
Financhill
Back

Astellas Pharma Stock Predictions

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
23

ALPMY
Astellas Pharma

Last Price:
10.13
Seasonality Move:
1.46%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

Astellas Pharma Stock Forecast

  • Over the next 52 weeks, Astellas Pharma has on average historically fallen by 1.9% based on the past 15 years of stock performance.
  • Astellas Pharma has fallen lower in 7 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 46.67%
  • Is Astellas Pharma Stock Undervalued?
    The current Astellas Pharma [ALPMY] share price is $10.13. The Score for ALPMY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • ALPMY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Astellas Pharma Stock Go Up Next Year?

  • Over the next 52 weeks, Astellas Pharma has on average historically fallen by 1.9% based on the past 15 years of stock performance.

Astellas Pharma Stock Rating

Sell
23
Astellas Pharma (ALPMY) is a Sell

Is Astellas Pharma overpriced?

  • Astellas Pharma has fallen lower in 7 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 46.67%

Astellas Pharma Stock Price History

Is ALPMY stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALPMY is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
OTCM
Country:
Japan
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
astellas.com

52-Week Data

52-Week High:
13.14
52-Week Low:
9.15

Prediction Charts

Market Cap:
18.13B
Price in USD:
10.13
Volume:
365.17K
Beta:
0.44

Technical Analysis

SMA50:
11.51
SMA100:
11.43
SMA200:
10.83
52-Wk Change:
-16.63%

Stock Predictions

  • Is Astellas Pharma stock public?
    Yes, Astellas Pharma is a publicly traded company.
  • What is the Astellas Pharma stock quote today?
    The Astellas Pharma stock price is 10.13 USD today.
  • How to buy Astellas Pharma stock online?
    You can buy Astellas Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-4 11.66 11.71 11.73 11.66
Nov-5 11.70 11.40 11.70 11.32
Nov-6 11.43 11.17 11.75 11.15
Nov-7 11.10 11.30 11.70 10.99
Nov-8 11.14 11.17 11.61 11.01
Nov-11 11.40 11.21 11.40 11.16
Nov-12 10.67 10.92 11.01 10.67
Nov-13 10.37 10.74 10.92 10.37
Nov-14 10.27 10.70 10.76 10.27
Nov-15 10.65 10.70 10.73 10.65
Nov-18 10.66 10.43 10.83 10.30
Nov-19 10.44 10.07 10.44 10.03
Nov-20 10.20 10.07 10.20 10.02
Nov-21 9.90 10.13 10.58 9.90

Astellas Pharma Earnings

Data Unavailable

Astellas Pharma Forecast Revenue Growth

Data Unavailable

* Astellas Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.